metricas
covid
Buscar en
Clínica e Investigación en Arteriosclerosis (English Edition)
Toda la web
Inicio Clínica e Investigación en Arteriosclerosis (English Edition) Decalogue of the Spanish Society of Arteriosclerosis to reduce therapeutic inert...
Journal Information

Statistics

Follow this link to access the full text of the article

Special article
Decalogue of the Spanish Society of Arteriosclerosis to reduce therapeutic inertia
Decálogo de la Sociedad Española de Arteriosclerosis para disminuir la inercia terapéutica
Mariano Blascoa, Pablo Pérez-Martínezb, Carlos Lahozc,
Corresponding author
clahoz.hciii@salud.madrid.org

Corresponding author.
a Facultad de Medicina, Zaragoza, Spain
b UGC Medicina Interna, Hospital Universitario Reina Sofía, IMIBIC/Universidad de Córdoba, Córdoba, Spain
c Unidad de Lípidos y Riesgo Vascular, Hospital Carlos III, Madrid, Spain
Read
437
Times
was read the article
107
Total PDF
330
Total HTML
Share statistics
Article information
ISSN: 25299123
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 December 11 0 11
2024 November 21 4 25
2024 October 10 3 13
2024 September 17 3 20
2024 August 16 2 18
2024 July 7 3 10
2024 June 8 4 12
2024 May 8 5 13
2024 April 14 4 18
2024 March 6 3 9
2024 February 8 2 10
2024 January 9 0 9
2023 December 7 1 8
2023 November 5 2 7
2023 October 5 2 7
2023 September 3 0 3
2023 August 8 1 9
2023 July 5 1 6
2023 June 9 2 11
2023 May 9 3 12
2023 April 2 0 2
2023 March 6 4 10
2023 February 15 6 21
2023 January 8 0 8
2022 December 13 2 15
2022 November 11 7 18
2022 October 9 2 11
2022 September 11 5 16
2022 August 7 9 16
2022 July 9 4 13
2022 June 11 6 17
2022 May 13 9 22
2022 April 9 3 12
2022 March 11 5 16
2022 February 9 0 9
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos